Thursday, October 4, 2012
Publication and contact
Assays & screens
receptor-capturing (LRC) technology to identify cell surface receptors of
therapeutic or pathologic ligands
LRC technology could be
used to identify cell surface receptor targets of ligands. The technology
uses a chemoreactive reagent that contains a glycosylated cell surface-binding
moiety, a biotin tag and an amino-reactive moiety, which binds to a ligand of
interest. In cell culture or tissue, the ligand-bound chemoreactive agent
attached to the ligand's cell surface receptor and the biotin tag was used to
purify the receptor for identification using mass spectroscopy. In various
cells, receptors for ligands, including insulin
and transferrin, were
identified. In cell culture, the LRC technology identified five
surface-binding proteins for vaccinia virus, which were verified using small
interfering RNA-mediated knockout of the receptors. Next steps include using
the platform for drug development.
Published online Oct. 4, 2012
Patent application filed;
available for licensing
Frei, A.P. et al. Nat.
Biotechnol.; published online Sept. 16, 2012;
Contact: Bernd Wollscheid, Swiss Federal Institute of
Technology Zurich (ETHZ), Zurich, Switzerland
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]